title: Breast Cancer Screening: Women's Experiences of Waiting for Further Testing.
abstract: OBJECTIVE
  To describe anxiety experienced by participants in a breast cancer screening program who have received an abnormal screening mammography result and are waiting for further testing and diagnosis and to identify the social support needed during this period.
  
  
  METHODS
  Exploratory, descriptive.
  
  
  METHODS
  Quebec Breast Cancer Screening Program (QBCSP) participants in Montreal, Canada.
  
  
  METHODS
  Nonprobability sample of 631 asymptomatic women, aged 50-69, who had abnormal screening mammogram results in the two months prior to the survey and who spoke or read French or English.
  
  
  METHODS
  Mailed self-report questionnaire.
  
  
  METHODS
  Anxiety, social support, and breast cancer screening.
  
  
  RESULTS
  Fifty-one percent of the participants were quite or very anxious at every stage of the prediagnostic phase. Seventy-five percent expressed their feelings to family and friends whose support was comforting but did not diminish participants' anxiety. Satisfaction from social support offered by healthcare professionals reduced their anxiety.
  
  
  CONCLUSIONS
  To decrease anxiety in the prediagnostic phase, women need support from healthcare professionals during the early stage of the screening process to prevent exacerbation of their concerns. Support has to be integrated into a continuity-of-care process.
  
  
  CONCLUSIONS
  Nurses can play a significant role in breast cancer screening programs. They can evaluate, at an early stage, participant anxiety and offer the appropriate social support. They also can ensure the follow-up and personalized support required while a patient awaits a diagnosis.
authors.affiliation: Quebec Action Network for the Health of Women, Montreal, Canada. ppineault@cooptel.qc.ca
authors.forename: Patricia
authors.initials: P
authors.lastname: Pineault
mesh_terms: D000223:Adaptation, Psychological; D000368:Aged; D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D001007:Anxiety / Q000188:drug therapy / Q000453:epidemiology; D001707:Biopsy, Needle / Q000523:psychology; D001943:Breast Neoplasms / Q000175:diagnosis* / Q000453:epidemiology / Q000451:nursing / Q000523:psychology*; D005260:Female; D019538:Health Care Surveys; D006801:Humans; D008327:Mammography / Q000523:psychology; D008875:Middle Aged; D009859:Oncology Nursing / Q000706:statistics & numerical data; D010353:Patient Education as Topic / Q000706:statistics & numerical data; D017060:Patient Satisfaction; D011369:Professional-Patient Relations; D011792:Quebec / Q000453:epidemiology; D012944:Social Support; D013997:Time Factors; D014850:Waiting Lists
chemical_list: D014151:Anti-Anxiety Agents